vimarsana.com

Page 12 - நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை பின்லாந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc

Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc Correction to the Invitation to the Annual General Meeting of Nexstim Plc In accordance with the invitation to the Annual General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) dated 15 April 2021, the shareholders of the Company have been invited to the Annual General Meeting to be held on 11 May 2021 commencing at 12.00 (EEST). The invitation to the meeting of 15 April 2021 includes a writing error stating that transfers of shares from the Company to the Receiving Shareholders required for the final adjustments of their number of shares (after reduction) are expected to take place and be recorded in book-entry accounts at the latest on 17th May 2021 in Sweden and 19th May 2021 in Finland. Notwithstanding the above-mentioned, the transfers of shares are expected to take place and be recorded in book-entry accounts at the latest on 17th May 2021 in Finland and 19th May 20

Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD

Nexstim Oyj Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression.

Nexstim Oyj: Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT Systems to Treat MDD

(0) Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT Systems to Treat MDD Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company s SmartFocus nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression. Oladele Adebogun M.D. said, I was initially introduced to Nexstim by the early outcomes of their registry which showed 50% remission rates in a small number of patients suffering from major depressive disorder. I purchased my first system and have been so impressed with my own patient outcomes that I have added this second system for my patients located in Flower Mound, Texas. I have even been able to successfully treat those patients who failed to respond to TMS on our prior non-Nexstim system. I am proud to contribute to the latest Nexstim treatment outcomes of triple the num

Nexstim Oyj: Nexstim Plc: Invitation to the Annual General Meeting

Nexstim Oyj: Nexstim Plc: Invitation to the Annual General Meeting Nexstim Plc: Invitation to the Annual General Meeting The Annual General Meeting of Nexstim Corporation (NXTMH: HEX, NXTMS: STO) ( Nexstim or the Company ) will be held on 11 May 2021 at 12:00 PM (EEST). The meeting will be held exceptionally without the presence of shareholders or their representatives at Nexstim s head office, Elimäenkatu 9 B (courtyard), 4th floor, 00510 Helsinki. The Board of Directors of the Company has decided on an exceptional general meeting procedure pursuant to the provisional act approved by the parliament on 15 September 2020 (the Provisional Act ). In order to limit the spread of the COVID-19 pandemic, the Annual General Meeting will be held without the presence of shareholders or their representatives at the venue. This is necessary so that the Annual General Meeting can be held in a predictable manner, taking into account the health and safety of shareholders, company personnel a

Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Nexstim Plc: Managers Transactions

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.